WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006117327) CELLULAR ASSAY METHOD FOR IDENTIFYING PKC-&thetas; INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/117327    International Application No.:    PCT/EP2006/061891
Publication Date: 09.11.2006 International Filing Date: 27.04.2006
IPC:
G01N 33/50 (2006.01), G01N 33/573 (2006.01), C12Q 1/48 (2006.01), C07K 16/40 (2006.01)
Applicants: NYCOMED GMBH [DE/DE]; Byk-Gulden-Str. 2, 78467 Konstanz (DE) (For All Designated States Except US).
HEIT, Isabelle [CH/CH]; (CH) (For US Only).
BAUDLER, Monika [DE/DE]; (DE) (For US Only).
DAMMEIER, Sascha [DE/DE]; (DE) (For US Only).
SCHÄFER, Michaela [DE/DE]; (DE) (For US Only).
BAIER, Gottfried [AT/AT]; (AT) (For US Only).
PAUL, Hubert [DE/DE]; (DE) (For US Only).
SHAW, Stephen Henry [US/US]; (US) (For US Only)
Inventors: HEIT, Isabelle; (CH).
BAUDLER, Monika; (DE).
DAMMEIER, Sascha; (DE).
SCHÄFER, Michaela; (DE).
BAIER, Gottfried; (AT).
PAUL, Hubert; (DE).
SHAW, Stephen Henry; (US)
Agent: MECHNICH, Oliver; c/o Nycomed GmbH, P.O. Box 100310, 78403 Konstanz (DE)
Priority Data:
102005020754.5 02.05.2005 DE
Title (EN) CELLULAR ASSAY METHOD FOR IDENTIFYING PKC-&thetas; INHIBITORS
(FR) METHODE DE DOSAGE CELLULAIRE POUR IDENTIFIER DES INHIBITEURS DE PKC-$G(U)
Abstract: front page image
(EN)The invention relates to a method for investigating the modulating effect of a test substance on a PKC&thetas;-dependent signal transduction pathway or for finding a PKC&thetas; modulator in a human or animal cell, including the steps (a) contacting the cell with the test substance or with the PKC&thetas; modulator ; (b) where appropriate inducing the kinase activity of PKC&thetas; ; (c) incubating the cell under conditions which bring about phosphorylation at least of a serine or threonine residue of PKC&thetas; ; (d) where appropriate lysing the cell ; and (e) determining the phosphorylation content of the at least one serine or threonine residue of PKC&thetas;.
(FR)L'invention porte sur une méthode visant à étudier l'effet de modulation d'une substance test sur un mécanisme d'action de transduction du signal dépendant de PKC? ou rechercher un modulateur de PKC? dans une cellule humaine ou animale, cette méthode consistant à: (a) mettre en contact la cellule avec la substance test ou avec le modulateur de PKC?; (b) si approprié, induire l'activité de la kinase de PKC?; (c) incuber la cellule dans des conditions qui amènent à la phosphorylation d'au moins un résidu de sérine ou thréonine de PKC?; (d) si approprié, lyser la cellule; et (e) déterminer la proportion de la phosphorylation d'au moins un résidu de sérine ou thréonine de PKC?.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)